Quantcast

Latest Biomarker Stories

2014-03-31 08:30:19

DALLAS, March 31, 2014 /PRNewswire/ -- According to a new market research report "Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) Instruments, Reagents & Services - Global Forecast to 2018", published by MarketsandMarkets, The market was valued at $10,223.0 Million in 2013 and is expected to grow at a healthy CAGR from 2013 to 2018. Browse 138...

2014-03-31 08:29:21

Submission follows positive data from U.S. pivotal study CASTLE ROCK, Colo., March 31, 2014 /PRNewswire/-- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1(TM) Test, a rapid, multiple biomarker-based index assay for identifying patients that are at low risk for appendicitis, today announced that it has filed a 510(k) premarket submission for the APPY1 Test. Venaxis(TM) has requested concurrent...

2014-03-30 23:00:57

This research report evaluates the global diagnostic imaging market with respect to the product market. The report analyzes geography; forecasting revenues, and trends. http://www.marketsandmarkets.com/Market-Reports/diagnostic-imaging-market-411.html (PRWEB) March 30, 2014 The “Global Diagnostic Imaging (CT, MRI, X-Ray & Ultrasound) Market - Competitive Landscape & Forecasts from 2010 to 2016” analyzes and studies the major market drivers, restraints, and opportunities in...

2014-03-26 23:03:44

New research report “Cancer Molecular Biomarkers 2014: A Global Market Study” worked out by Biopharm Reports is now available at MarketPublishers.com London, UK (PRWEB) March 26, 2014 Tremendous advances in the molecular biology field during the recent decade are boosting the development and introduction of novel nucleic acid diagnostic tests. Furthermore, these advances open nice opportunities for the creation of simpler, faster and more standardized tests, testing platforms as well...

2014-03-21 23:25:53

As part of its $219,000 initial multiple system atrophy research grant funding round, The MSA Coalition® has awarded $25,00 to Dr. Roy Freeman of Beth Israel Deaconess Medical Center for research to determine whether alpha-synuclein deposits are a valid biomarker for multiple system atrophy. Boston, MA (PRWEB) March 21, 2014 The Multiple System Atrophy Coalition has awarded a $25,000 grant to Dr. Roy Freeman of Beth Israel Deaconess Medical Center to carry out a pilot study to...

2014-03-21 08:23:43

INNSBRUCK, Austria, March 21, 2014 /PRNewswire/ -- - A US research team has developed the world's first blood test capable of predicting, with 90% accuracy, the risk of Alzheimer's disease 2-3 years in advance. The findings, published in Nature Medicine, were generated using the AbsoluteIDQ(R) p180 test kit by Austrian BIOCRATES Life Sciences AG. A team of US researchers has developed the world's first blood test capable of predicting Alzheimer's. The...

2014-03-18 23:26:23

Launch of ADDPLAN® 6.1 to Expedite and Improve Decision-Making in Clinical Trials Reston, Virginia (PRWEB) March 18, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of product development, today announced the release of ADDPLAN® 6.1, the first statistical software to enable the use of surrogate endpoints to...

2014-03-17 16:28:51

Project Leverages Luminex's xMAP® Technology for Biobank Profiling Research AUSTIN, Texas, March 17, 2014 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that xMAP® Technology is playing a key role in the biobank profiling research within the Human Protein Atlas (HPA) project. In the latest release of the protein atlas, the HPA announced coverage of over 80% of the human protein-coding genes and RNA expression data for more than 90% of the genes....

2014-03-13 23:21:34

The expanding use of immunoassays, increasing demand for high quality healthcare services, and rapidly increasing geriatric population are the major factors that drives the global market. http://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html (PRWEB) March 13, 2014 The "Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End...

Blood Test Shows Risk Of Alzheimer’s Disease, Cognitive Decline
2014-03-11 09:34:17

April Flowers for redOrbit.com – Your Universe Online A new study, led by Georgetown University, reveals that a blood test has been discovered and validated that can predict, with 90 percent accuracy, if a healthy person will develop mild cognitive impairment or Alzheimer's disease within three years. The study, published in Nature Medicine, indicates the possibility of developing treatment strategies for Alzheimer's at an earlier stage. Therapy at these earlier stages would be more...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.